Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20,907,188
-
Total 13F shares
-
23,362,159
-
Share change
-
+1,933,860
-
Total reported value
-
$886,031,367
-
Put/Call ratio
-
120%
-
Price per share
-
$37.87
-
Number of holders
-
147
-
Value change
-
+$1,335,704
-
Number of buys
-
79
-
Number of sells
-
96
Institutional Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q1 2025
As of 31 Mar 2025,
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) was held by
147 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,362,159 shares.
The largest 10 holders included
Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, BlackRock, Inc., MORGAN STANLEY, Soleus Capital Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, VR ADVISER, LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
147
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.